[Federal Register: June 10, 2010 (Volume 75, Number 111)]
[Notices]
[Page 32988-32989]
[DOCID:fr10jn10-89]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

[Docket No. FAA-2010-0109]

Notice on Waiver of the Terms of the Order Limiting Scheduled
Operations at LaGuardia Airport

ACTION: Extension of Time for Delta Airlines and US Airways to Notify
the FAA of Intent to Proceed with Slot Transfer Transaction.

-----------------------------------------------------------------------

SUMMARY: This action extends the deadline to July 2, 2010, for Delta
and US Airways to notify the FAA whether they intend to proceed with
the slot transfer transaction subject to the Waiver of the Terms of the
Order Limiting Scheduled Operations at LaGuardia Airport.
    If you wish to review the background documents or comments received
in this proceeding, you may go to http://www.regulations.gov at any
time and follow the online instructions for accessing the electronic
docket. You may also go to the U.S. Department of Transportation's
Docket Operations in Room W12-140 on the ground floor of the West
Building at 1200 New Jersey Avenue, SE., Washington, DC between 9 a.m.
and 5 p.m. Monday through Friday, except Federal holidays.

DATES: Delta and US Airways must notify the FAA in writing by July 2,
2010, as to whether they intend to proceed with the slot transfer
transaction as described in the Notice issued May 4, 2010. The waiver
is effective upon Delta and US Airways satisfying the conditions
required by that Notice, as amended by this extension of time.

FOR FURTHER INFORMATION CONTACT: Rebecca MacPherson, Assistant Chief
Counsel for Regulations, by telephone at<PHONE_NUMBER> or by
electronic mail at<EMAIL_ADDRESS>or Jonathan Moss, Deputy
Assistant General Counsel for Operations, by telephone at (202) 366-
4710 or by electronic mail at<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION:
    On May 4, 2010, Ray LaHood, Secretary of the Department of
Transportation (DOT) and J. Randolph Babbitt, FAA Administrator,
granted, subject to conditions, a joint waiver request of Delta Air
Lines and US Airways from the prohibitions on purchasing operating
authorizations (``slots'' or ``slot interests'') at LaGuardia Airport
(LGA). Notice on Petition for Waiver of the Terms of the Order Limiting
Scheduled Operations at LaGuardia Airport, 75 Federal Register 26,322
(May 11, 2010) (hereinafter, the ``Waiver'').
    The Waiver permits the carriers to consummate a transaction in
which Delta would transfer 42 pairs of slot interests to US Airways at
Ronald Reagan Washington National Airport (DCA), international route
authorities to Sao Paulo and Tokyo; and terminal space at the Marine
Air Terminal at LaGuardia Airport (LGA). US Airways would transfer 125
pairs of slot interests to Delta at LGA, and lease an additional 15
pairs of LGA slot interests with a purchase option, together with
terminal space in LGA's Terminal C. The grant is subject to the
conditions that the carriers dispose of 14 pairs of slot interests at
DCA and 24 pairs of slot interests at LGA to eligible new entrant and
limited incumbent carriers pursuant to certain procedures and achieve a
mutually satisfactory agreement regarding gates and associated
facilities with any such purchaser.
    The Waiver also requires Delta and US Airways to notify the FAA, in
writing, within 30 days, whether they intend to proceed with the slot
transfer transaction. If they intend to consummate the slot transfer
transaction subject to the waiver, their notice must provide the
following information for the divested slots:
    (1) Operating Authorization number (LGA) or slot number (DCA) and
time;
    (2) Frequency;
    (3) Effective Date(s);
    (4) Other pertinent information, if applicable; and
    (5) Carrier's authorized representative.\1\
---------------------------------------------------------------------------

    \1\ 75 FR 26,322 at 26,337 (May 11, 2010).
---------------------------------------------------------------------------

    On June 3, 2010, Delta and US Airways jointly filed a letter
requesting an extension of the deadline until July 2, 2010. The FAA
finds that granting this extension of time would not adversely affect
the public interest.

    Accordingly, the FAA grants this request for extension, and Delta
and US Airways must notify, in writing, the FAA whether they intend to
proceed with the slot transfer transaction by July 2, 2010.

    Issued in Washington, DC, on June 4, 2010.
David Grizzle,
Acting Deputy Administrator, Federal Aviation Administration.
Susan Kurland.
Assistant Secretary for Aviation and International Affairs.
[FR Doc. 2010-13904 Filed 6-9-10; 8:45 am]
BILLING CODE 4910-13-P


[Federal Register Volume 78, Number 86 (Friday, May 3, 2013)]
[Notices]
[Pages 26091-26092]
[FR Doc No: 2013-10483]

=======================================================================
-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[Release No. IC-30495]

Notice of Applications for Deregistration Under the Investment
Company Act of 1940

April 26, 2013.
    The following is a notice of applications for deregistration under
section 8(f) of the Investment Company Act of 1940 for the month of
April 2013. A copy of each application may be obtained via the
Commission's Web site by searching for the file number, or for an
applicant using the Company name box, at http://www.sec.gov/search/search.htm or by calling<PHONE_NUMBER>. An order granting each
application will be issued unless the SEC orders a hearing. Interested
persons may request a hearing on any application by writing to the
SEC's Secretary at the address below and serving the relevant applicant
with a copy of the request, personally or by mail. Hearing requests
should be received by the SEC by 5:30 p.m. on May 21, 2013, and should
be accompanied by proof of service on the applicant, in the form of an
affidavit or, for lawyers, a certificate of service. Hearing requests
should state the nature of the writer's interest, the reason for the
request, and the issues contested. Persons who wish to be notified of a
hearing may request notification by writing to the Secretary, U.S.
Securities and Exchange Commission, 100 F Street, NE., Washington, DC
20549-1090.

FOR FURTHER INFORMATION CONTACT: Diane L. Titus at<PHONE_NUMBER>, SEC,
Division of Investment Management, Exemptive Applications Office, 100 F
Street NE., Washington, DC 20549-8010.

2009 Dole Food Automatic Common Exchange Security Trust [File No. 811-
22342]

    Summary: Applicant, a closed-end investment company, seeks an order
declaring that it has ceased to be an investment company. On November
1, 2012 and November 29, 2012, applicant made liquidating distributions
to its shareholders, based on net asset value.

Expenses incurred in connection with the liquidation were paid by David
H. Murdock as trustee of the David H. Murdock Living Trust.
    Filing Dates: The application was filed on March 13, 2013, and
amended on April 2, 2013.
    Applicant's Address: c/o U.S. Bank National Association, Corporate
Trust Services, 633 West 5th St., 24th Floor, LM-CA T24T, Los Angeles,
CA 90071.

Ameristock Mutual Fund Inc. [File No. 811-9090]

    Summary: Applicant seeks an order declaring that it has ceased to
be an investment company. The applicant has transferred its assets to
Drexel Hamilton Centre American Equity Fund, a series of Drexel
Hamilton Mutual Funds, and on January 11, 2013, made a final
distribution to its shareholders based on net asset value. Expenses of
approximately $1,247,282 incurred in connection with the reorganization
were paid by Drexel Hamilton Investment Partners, LLC, investment
adviser to the acquiring fund, and Ameristock Corporation, applicant's
investment adviser.
    Filing Dates: The application was filed on February 19, 2013, and
amended on April 11, 2013.
    Applicant's Address: 1320 Harbor Bay Pwky., Suite 145, Alameda, CA
94502.

Morgan Stanley Mid Cap Growth Fund [File No. 811-3639]

    Summary: Applicant seeks an order declaring that it has ceased to
be an investment company. The applicant has transferred its assets to
Mid Cap Growth Portfolio, a series of Morgan Stanley Institutional Fund
Trust, and on October 29, 2012, applicant made a final distribution to
its shareholders based on net asset value. Expenses of approximately
$326,809 incurred in connection with the reorganization were paid by
applicant.
    Filing Date: The application was filed on March 22, 2013.
    Applicant's Address: c/o Morgan Stanley Investment Management Inc.,
522 Fifth Ave., New York, NY 10036.

Morgan Stanley Global Strategist Fund [File No. 811-5634]

    Summary: Applicant seeks an order declaring that it has ceased to
be an investment company. The applicant has transferred its assets to
Global Strategist Portfolio, a series of Morgan Stanley Institutional
Fund Trust and, on October 29, 2012, made final distribution to its
shareholders based on net asset value. Expenses of approximately
$399,385 incurred in connection with the reorganization were paid by
applicant.
    Filing Date: The application was filed on March 22, 2013.
    Applicant's Address: c/o Morgan Stanley Investment Management Inc.,
522 Fifth Ave., New York, NY 10036.

Morgan Stanley International Fund [File No. 811-9081]; Morgan Stanley
International Value Equity Fund [File No. 811-10273]

    Summary: Each applicant seeks an order declaring that it has ceased
to be an investment company. The applicants have transferred their
assets to Active International Allocation Portfolio and International
Equity Portfolio, each a series of Morgan Stanley Institutional Fund,
Inc. and, on October 29, 2012, made a final distribution to their
shareholders based on net asset value. Expenses of approximately
$224,591 and $375,957, respectively, incurred in connection with the
reorganizations were paid by applicants.
    Filing Date: The applications were filed on March 22, 2013.
    Applicant's Address: c/o Morgan Stanley Investment Management Inc.,
522 Fifth Ave., New York, NY 10036.

Central Park Group Multi-Event Fund [File No. 811-21984]

    Summary: Applicant, a closed-end investment company, seeks an order
declaring that it has ceased to be an investment company. On December
31, 2012, applicant made a final liquidating distribution to its
shareholders, based on net asset value. Expenses of $11,000 incurred in
connection with the liquidation were paid by applicant.
    Filing Date: The application was filed on March 25, 2013.
    Applicant's Address: c/o Central Park Advisers, LLC, 805 Third Ave,
New York, NY 10022.

Excelsior Multi-Strategy Hedge Fund of Funds (TI 2), LLC [File No. 811-
22317]

    Summary: Applicant, a closed-end investment company, seeks an order
declaring that it has ceased to be an investment company. On March 15,
2013, applicant made a final liquidating distribution to its
shareholders, based on net asset value. Expenses of $25,000 incurred in
connection with the liquidation were paid by applicant.
    Filing Date: The application was filed on April 5, 2013.
    Applicant's Address: 225 High Ridge Rd., Stamford, CT 06905.

John Hancock Flexible Income Opportunities Fund [File No. 811-22587]

    Summary: Applicant, a closed-end investment company, seeks an order
declaring that it has ceased to be an investment company. Applicant has
never made a public offering of its securities and does not propose to
engage in business of any kind.
    Filing Date: The application was filed on April 8, 2013.
    Applicant's Address: 601 Congress St., Boston, MA 02210.

Diamond Hill Financial Trends Fund, Inc. [File No. 811-5734]

    Summary: Applicant, a closed-end investment company, seeks an order
declaring that it has ceased to be an investment company. On March 22,
2013, applicant made a liquidating distribution to its shareholders,
based on net asset value. Applicant represents that fewer than one
percent of its shareholders have not yet received distributions in
complete liquidation of their interests. The paying agent,
Computershare Share Owners Services, LLC, is holding funds for these
shareholders until they surrender their physical share certificates.
Expenses of $202,616 incurred in connection with the liquidation were
paid by applicant.
    Filing Date: The application was filed on April 10, 2013.
    Applicant's Address: 325 John H. McConnell Blvd., Suite 200,
Columbus, OH 43215.

Performance Funds Trust [File No. 811-6603]

    Summary: Applicant seeks an order declaring that it has ceased to
be an investment company. The applicant has transferred its assets to
corresponding series of Money Market Obligations Trust, Federated
Equity Funds, Federated Total Return Series, Inc. and Federated U.S.
Government Securities Fund: 1-3 Years and, on September 21, 2012, made
a final distribution to its shareholders based on net asset value.
Expenses of $666,121 incurred in connection with the reorganization
were paid by Trustmark Investment Advisors, Inc., applicant's
investment adviser.
    Filing Date: The application was filed on April 2, 2013.
    Applicant's Address: 3435 Stelzer Rd., Columbus, OH 43219.

    For the Commission, by the Division of Investment Management,
pursuant to delegated authority.
Kevin M. O'Neill,
Deputy Secretary.
[FR Doc. 2013-10483 Filed 5-2-13; 8:45 am]
BILLING CODE 8011-01-P


[Federal Register: December 7, 2007 (Volume 72, Number 235)]
[Notices]
[Page 69262-69263]
[DOCID:fr07de07-90]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISISON

[Release No. 34-56873; File No. SR-CBOT-2007-01]

Self-Regulatory Organization; Board of Trade of the City of
Chicago, Inc.; Notice of Filing and Immediate Effectiveness of Proposed
Rule Changes Relating to the Renumbering and Reorganization of Rules
Relating to Listing Standards for Security Futures Products

November 30, 2007.
    Pursuant to section 19(b)(7) of the Securities Exchange Act of 1934
(``Act''),\1\ and Rule 19b-7 under the Act,\2\ notice is hereby given
that on November 1, 2007, the Board of Trade of the City of Chicago,
Inc. (``CBOT[supreg]'' or ``Exchange'') filed with the Securities and
Exchange Commission (``Commission'') the proposed rules described in
Items I, II, and III below, which Items have been substantially
prepared by the CBOT. The Commission is publishing this notice to
solicit comments on the proposed rules from interested persons. The
CBOT also has filed the proposed rules with the Commodity Futures
Trading Commission (``CFTC''), together with a written certification
under section 5c(c) of the Commodity Exchange Act (``CEA'') \3\ on
October 25, 2007.
---------------------------------------------------------------------------

    \1\ 15 U.S.C. 78s(b)(7).
    \2\ 17 CFR 240.19b-7.
    \3\ 7 U.S.C. 7a-2(c).
---------------------------------------------------------------------------

I. Self-Regulatory Organization's Description of the Proposed Rules

    The proposed rule changes delete CBOT Rulebook Chapter 57 (Single
Stock Futures) and Chapter 58 (Narrow-Based Stock Index Futures) in
their entirety and substitute new CBOT Rulebook Chapter 34 (Single
Stock Futures) and Chapter 35 (Narrow-Based Stock Index Futures). In
addition, the proposed rule changes renumber current CBOT Regulations
431.07 (Customer Margins for Security Futures Positions Held in Futures
Accounts) and 431.08 (Acceptable Margin for Security Futures and
Treatment of Undermargined Accounts) as Rules 931 and 932.
    The text of the proposed rule change is available on the Exchange's
Web site (http://www.cmegroup.com), at the Exchange's principal office,

and at the Commission's Public Reference Room.

II. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rules

    The CBOT has prepared statements concerning the purpose of, and
basis for, the proposed rules, burdens on competition, and comments
received from members, participants, and others. The text of these
statements may be examined at the places specified in Item IV below.
These statements are set forth in sections A, B, and C below.

A. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rules

1. Purpose
    The CBOT has proposed to substitute new rulebook Chapters 34 and 35
for current Chapters 57 and 58, and to renumber current Regulations
431.07 and 431.08 as Rules 931 and 932 in connection with the adoption
of a new rulebook for the CBOT as a result of the merger between the
CBOT's former holding company, CBOT Holdings, Inc., and the former
holding company of Chicago Mercantile Exchange Inc., CME Holdings Inc.,
to form the CME Group.\4\ The CBOT is adopting a new rulebook, in order
to harmonize its rules with those of Chicago Mercantile Exchange Inc.
(``CME''), which utilizes the formatting and numbering system of the
CME rulebook. New CBOT rulebook Chapters 34 and 35 mirror current CBOT
Chapters 57 and 58 in content, although the organization and numbering
of the rules has changed. Several minor non-substantive changes have
also been made, as follows: (1) All references to the ``Clearing
Services Provider'' have been changed to the ``Clearing House'' to
reflect the new relationship of the CME Clearing House to the CBOT
post-merger; (2) all references to CBOT ``regulations'' have been
changed to ``rules'' because the CBOT will no longer make any
distinctions between Exchange ``rules'' and ``regulations''; and (3)
current Regulation 5702.01 and its parallel Regulation 5802.01
(Emergencies, Acts of God, Acts of Government) have been deleted as
unnecessary since the CBOT is adopting a similar Rule in its new
Chapter 7 (Delivery Facilities and

Delivery Procedures) that applies generally to all CBOT products.\5\
New Rules 931 and 932 are identical to current Regulations 431.07 and
431.08.
---------------------------------------------------------------------------

    \4\ The CBOT certified its new rulebook to the CFTC on October
25, 2007, notifying the CFTC that most of its new rules would be
implemented on November 29, 2007, including the proposed rule
changes that are addressed in this filing.
    \5\ See CBOT Rule 701, as certified to the CFTC on October 25,
2007.
---------------------------------------------------------------------------

2. Statutory Basis
    The Exchange has filed these proposed regulations pursuant to
section 19(b)(7) of the Act.\6\ The CBOT believes that these rules, as
renumbered and reorganized, continue to be authorized by, and
consistent with, section 6(b)(5) of the Act,\7\ because they are
designed to prevent fraudulent and manipulative acts and practices, to
promote just and equitable principles of trade, and to protect
investors and the public interest.
---------------------------------------------------------------------------

    \6\ 15 U.S.C. 78s(b)(7).
    \7\ 15 U.S.C. 78f(b)(5).
---------------------------------------------------------------------------

B. Self-Regulatory Organization's Statement on Burden on Competition

    The CBOT does not believe that the proposed rule changes will
impose any burden on competition that is not necessary or appropriate
in furtherance of the purposes of the Act. Since the proposed rule
changes will permit the CBOT to provide a trading venue for security
futures, these rules will serve to enhance and promote competition.

C. Self-Regulatory Organization's Statement on Comments on the Proposed
Rules Received From Members, Participants, or Others

    The CBOT neither solicited nor received any written comments on the
proposed regulations.

III. Date of Effectiveness of the Proposed Rules and Timing for
Commission Action

    Pursuant to section 19(b)(7)(B) of the Act,\8\ the proposed
regulations became effective on October 26, 2007.\9\ Within 60 days of
the date of effectiveness of the proposed regulations, the Commission,
after consultation with the CFTC, may summarily abrogate the proposed
regulations and require that the proposed regulations be re-filed in
accordance with the provisions of section 19(b)(1) of the Act.\10\
---------------------------------------------------------------------------

    \8\ 15 U.S.C. 78s(b)(7)(B).
    \9\ The CBOT filed the proposed regulations with the CFTC,
together with a written certification under Section 5c(c) of the
CEA, 7 U.S.C. 7a-2(c), on October 25, 2007.
    \10\ 15 U.S.C. 78s(b)(1).
---------------------------------------------------------------------------

IV. Solicitation of Comments

    Interested persons are invited to submit written data, views, and
arguments concerning the foregoing, including whether the proposed rule
change is consistent with the Act. Comments may be submitted by any of
the following methods:

Electronic Comments

     Use the Commission's Internet comment form (http://www.sec.gov/rules/sro.shtml.
); or     Send an e-mail to<EMAIL_ADDRESS>Please include

File Number SR-CBOT-2007-01 on the subject line.

Paper Comments

     Send paper comments in triplicate to Nancy M. Morris,
Secretary, Securities and Exchange Commission, 100 F Street, NE.,
Washington, DC 20549-1090.

All submissions should refer to File Number SR-CBOT-2007-01. This file
number should be included on the subject line if e-mail is used. To
help the Commission process and review your comments more efficiently,
please use only one method. The Commission will post all comments on
the Commission's Internet Web site (http://www.sec.gov/rules/sro.shtml
). Copies of the submission, all subsequent amendments, all

written statements with respect to the proposed rule change that are
filed with the Commission, and all written communications relating to
the proposed rule change between the Commission and any person, other
than those that may be withheld from the public in accordance with the
provisions of 5 U.S.C. 552, will be available for inspection and
copying in the Commission's Public Reference Room, 100 F Street, NE.,
Washington, DC 20549, on official business days between the hours of 10
a.m. and 3 p.m. Copies of such filing will also be available for
inspection and copying at the principal office of the CBOT. All
comments received will be posted without change; the Commission does
not edit identifying personal information from submissions. You should
submit only information that you wish to make available publicly. All
submissions should refer to File No. SR-CBOT-2007-01 and should be
submitted on or before December 28, 2007.
---------------------------------------------------------------------------

    \11\ 17 CFR 200.30-3(a)(73).

    For the Commission by the Division of Trading and Markets,
pursuant to delegated authority.\11\
Florence E. Harmon,
Deputy Secretary.
[FR Doc. E7-23721 Filed 12-6-07; 8:45 am]

BILLING CODE 8011-01-P


Page 1 of 9 Cl O OH O O Cl Cl OH O Appendix B: Toxicity Studies with 4 chlorophenoxyacetic acid ( 4 CPA) and Structures Related to 4 CPA.

Structure of 4 chlorophenoxyacetic acid ( 4 CPA) ( PC 019401)

The following are brief summaries of the cancer findings for each of the structural analogs for which there are studies. In some cases the Cancer Assessment Review Committee ( CARC) has not evaluated the pesticide. Comparison of the results from toxicity studies are made for 4 CPA and the four analogs, 2,4 dichlorophenoxyacetic acid, 2 methyl 4 chlorophenoxyacetic acid, 3 chlorophenoxy 2 propionic acid, and 2 methyl 4 chlorophenoxybutyric acid ( Table 1). More structurally remote chlorophenoxy acid pesticides are: ( 1) 2,4 dichlorophenoxybutyric ( not carcinogenic in rats or mice), ( 2) 2,4 dichlorophenoxy 2 propionic acid ( not carcinogenic in rats or mice), ( 3) 2,4,5 trichlorophenoxyacetic acid ( evidence of carcinogenicity in total tumors in female mice, but not rats), and ( 4) 2,4,5 trichlorophenoxy 2 propionic acid ( no studies available). These latter pesticides are not shown and not summarized further. [ Information from Carcinogenicity Peer Review ( 4th) of 2,4 D, 1/ 29/ 97.] ______________________________________________________________________________

Although there are no carcinogenicity studies on 4 CPA, the weight of the evidence does not suggest that 4 CPA would be carcinogenic in life time studies at reasonable doses not causing excessive toxicity.

Structure of 2,4 dichlorophenoxyacetic acid ( 2,4 D)( PC 030001)

The following is a summary of the findings from the fourth and last cancer assessment of 2,4 D. This pesticide has the largest toxicity data base of all the analogs. The Cancer Peer Review Committee ( CPRC) concluded that 2,4 D should remain classified as a " Group D"  Not classifiable as to a human carcinogenicity. That is, the evidence is inadequate and cannot be interpreted as showing either the presence or the absence of a carcinogenic effect. 2,4 D was initially classified as a possible human carcinogen, based on a significant increased trend for brain astrocytomas in male Fisher 344 rats and suggestive to weak and conflicting evidence of non Hodgkin's lymphoma from several epidemiological studies. There was no evidence of tumor induction in female rats or male or female B6C3F1 mice, however, the CPRC concluded that the highest dose tested in both studies was sufficiently toxic to adequately test for carcinogenicity. Repeat studies were conducted in rats and mice at adequate doses, but neither study showed statistically significantly increased tumor incidence in either species or sex. Page 2 of 9 O CH 3 Cl OH O O Cl CH 3 O ONa Mutagenicity studies showed consistently negative results without activation and positive and negative result with activation. The CPRC concluded that although cytogenic activity was seen, there was no concern for mutagenicity. Metabolism studies in the rat indicated that 85 to 94% of the parent was excreted unchanged in the urine with 0%  1.3% of 2 uncharacterized compounds and 4 to 10% was excreted as the parent in feces. Total excretion ( 98 to 99.5%) occurred within 48 hours. The CPRC and SAP agreed on a " Group D" classification. [ Information from Carcinogenicity Peer Review ( 4th) of 2,4 D, 1/ 29/ 97.]

Structure and results on 2 methyl 4 chlorophenoxyacetic acid ( MCPA) ( PC 030501)

MCPA has not been reviewed by the CARC, but a toxicology reviewer indicated that no dose related tumors were seen in rats or mice at adequate doses to test for carcinogenicity. A battery of mutagenicity studies shows a positive study for chromosomal aberrations in human lymphocyte cells and weakly mutagenic response in an in vivo sister chromatid exchange study. The remaining 6 in vivo and in vitro mutagenicity studies conducted were negative. The metabolism studies in the rat shows that MCPA is excreted in the urine ( 74 86%; 53% 69% as the parent and 7 13% as the hydroxymethyl metabolite and 2 5% in the feces). Total excretion occurred within 192 hours ( 98%). [ Information from the 1 liners and Paul Chin reviewer].

Structure and results on sodium 3 chlorophenoxy 2 propionate ( cloprop, sodium salt) ( PC 021201)

Life time carcinogenicity studies have been conducted with cloprop, but there are no definitive conclusions. There was a statistically significantly increasing trend and pair wise comparison with control for mortality in male and female rats at the top dose. The registrant refused to submit historical control data on morality among the rats used in the carcinogenicity study. Consequently the Peer Review of cloprop was canceled and the pesticide withdrawn. In the mouse study, there was statistically significantly pair wise comparison of male liver adenomas/ carcinomas and male liver carcinomas at the highest dose tested and in females for liver adenomas and carcinomas at the two lowest doses tested, but not at the highest dose tested. One reviewer believed that there was no evidence for carcinogenicity in mice, however another reviewer believed there was evidence of liver cancer in mice. The issue has never been resolved because the pesticide was withdrawn. Cloprop is negative in a battery of mutagenicity studies. There are no metabolism studies in rats, but in goats, cloprop is excreted as the parent. [ Information from 1 liners and a memorandum from John Redden.] Page 3 of 9 Cl CH 3 O OH O Structure and results on 2 methyl 4 chlorophenoxybutryic acid ( MCPB) ( PC 019201)

No life time carcinogenicity studies have been conducted with MCPB. A battery of mutagenicity studies are negative. One study for chromosomal abnormalities with S9 produced chromosomal abnormalities at high doses. There are no adequate metabolism studies, but a reference from the literature suggest that bacteria split off acetic acid from the butyric acid residue in plants and cows. [ Information from 1 liners and DERs.]

Structure and results on 2( 4 chlorophenoxy) 2 methylpropanoic acid ethyl ester; the Drug Clofibrate ( lowers plasma triglycerides and cholesterol)

An International Agency for Research on Cancer ( IARC) Monograph on clofibrate states that there is inadequate evidence in humans for carcinogenicity and limited evidence in animals for carcinogenicity. Clofibrate is peroxisome proliferator and is excreted rapidly in human urine as the parent. ( http:// <IP_ADDRESS>/ htdocs/ monographs/ vol66/ clofibrate. html).

Structure and results on mecoprop [ 2( 2 methyl 4 chlorophenoxy) propionic acid] ( PC 031501)

The acute toxicity of mecoprop is similar to that of 4 CPA. The NOAEL/ LOAEL in the rat 90 day feeding study was lower than the NOAEL/ LOAEL in rat 90 day neurotoxicity study, which showed no neurotoxic effects, in addition to being lower than 4 CPA in a rat 90 day feeding study. A rabbit developmental toxicity study showed a maternal NOAEL/ LOAEL of 30/ 75 mg/ kg/ day, but no developmental toxicity at the highest dose tested. The rat developmental toxicity study showed developmental toxicity in the form of decreased crown rump lengths, decreased ossification of sternebrae and increased intrauterine death at the highest dose tested, which was a maternally toxic dose. The rat developmental effects occurred at a lower dose than the effects from 4 CPA in a rat developmental toxicity study. No 90 day feeding study in dogs is available. Potential carcinogenic effects have not been fully evaluated as yet, but there is suggestive evidence for increased liver tumors in mice. The rat carcinogenicity study was negative. A reverse gene mutation study was acceptable and negative and chromosomal aberrations study was acceptable and negative for clastogenicity ( MRID# 41013909, TXR# 009589). The remaining mutagenicity studies were unacceptable. Page 4 of 9 Cl O OH O O Cl Cl OH O O CH 3 Cl OH O O Cl CH 3 O ONa Cl CH 3 O OH O Table 1: Comparison of toxicity studies/ results for 4 chlorophenoxyacetic acid ( 4 CPA) and four analogs of 4 CPA Study/ Test 4 chloro phenoxyacetic acid ( 4 CPA)

019401 Data from DERs &

Peer Rev ( 2,4 dichlorophenoxy) 2

acetic acid ( 2,4 D)

030001 Data from 1 Liner & Peer Rev ( 2 methyl 4

chlorophenoxy 2 acetic acid ( MCPA)

030501 Data from 1 Liner &

Paul Chin sodium ( 3 chlorophenoxy)  2

propionate ( cloprop, sodium salt)

021201 Data from 1 Liner No info in Archives ( 2 methyl 4 chlorophenoxy) 4

butyric acid ( MCPB)

019201 Data from 1 Liner Results on ( a. i.) Results on ( a. i.) Results on ( a. i.) Results on ( a. i.) Results on ( a. i.)

870.1100 Acute Oral ToxicityLD50 870.1200 Acute Dermal Toxicity/ LD50 . . . . . . . .

870.1300 Acute Inhalation Toxicity/ LC50 . . . . . . . .

870.2400 Primary Eye Irritation . .

870.2500 Primary Dermal Irritation 870.2600 Dermal Sensitization . . . 2703 mg/ kg > 2000 mg/ kg > 5.25 mg/ L Severe Not irritating Not sensitizing 3730mg/ kg > 2000 mg/ kg > 1.8 mg/ L 4hr Mod/ Severe None Irritating Not sensitizing 3500 mg/ kg > 2000mg/ kg > 6.3 mg/ L Mod/ Severe Slight Not sensitizing 1567 mg/ kg

 1570 mg/ kg 1000 mg/ kg 1.1 mg/ L ( acetone vehicle)

Mod/ Severe

870.3100 Oral Subchronic ( rat) . . . N/ L= 152/ 517mkd,

Bwt dec & urine volume inc, liver individual cell necrosis N/ L= 15/ 100mkd testes,

liver, thyroid weight inc & spleen histop N/ L= 50/ 150ppm N/ L= 2.5/ 7.5 mkd inc kidney weight with incr creatinine HDT, no histop  N/ L= 158/ m/ k/ d HDT palatability noted;

kidney weight incr,

histop neg 870.3150 Oral Subchronic ( dog) . . N/ L= 18.6/ mkd HDT ( Peer Rev);

N/ L= 3.3/ 19mkd bwt &

food decr; no histop changes seen ( DER) N/ L= 1.0/ 3.0 mkd, liver,

kidney & testes histo N/ L= 0.6/ 2.4 mkd liver inflammation & clinical chemistry ( MCPADimethylamine N/ L= 12.5/ 50 mkd,

bwt decr, liver,

kidney & spleen weight incr N/ L= 12/ 40mkd Inc BSP retention, dec spermatogenic activity,

prostate & testes tubular atrophy Cl O OH O O Cl Cl OH O O CH 3 Cl OH O O Cl CH 3 O ONa Cl CH 3 O OH O Study/ Test 4 chloro phenoxyacetic acid ( 4 CPA)

019401 Data from DERs &

Peer Rev ( 2,4 dichlorophenoxy) 2

acetic acid ( 2,4 D)

030001 Data from 1 Liner & Peer Rev ( 2 methyl 4

chlorophenoxy 2 acetic acid ( MCPA)

030501 Data from 1 Liner &

Paul Chin sodium ( 3 chlorophenoxy)  2

propionate ( cloprop, sodium salt)

021201 Data from 1 Liner No info in Archives ( 2 methyl 4 chlorophenoxy) 4

butyric acid ( MCPB)

019201 Data from 1 Liner Page 5 of 9 870.3200 21 Day Dermal ( rabbit) .

870.3250 90 Day Dermal . . . . . . .

870.3465 90 Day Inhalation . . . . .

 N/ L= 1000/ mkd  SystN/ L= 100/ 1000mkd Mineralization kidney tubules IrritationN/ L=

10/ 100mkd

870.3700a Developmental Toxicity ( rat) . . . . . . . . . . . . . . . . M N/ L= 150/ 300mkd Bwt dec & at 1000mkd mortality, tremors &

uncoordinated movements D N/ L= 150/ 300mkd sternebrae unoss M N/ L= 25/ 75mkd decr Bwt D N/ L= 25/ 75mkd, extra rib, dec oss, variations M N/ L= 60/ 120 mkd Bwt D N/ L= 60/ 120 mkd Dec Bwt & dec oss M N/ L= 400/ mkd HDT D N/ L= 400/ mkd UA, OPP added;

acceptable with rabbit study M N/ L= 25/ 100 mkd, bwt; D N/ L= 25/ 100mkd, dec oss 870.3700b Developmental Toxicity ( rabbit) . . . . . . . . . . . . . M N/ L= 25/ B mkd, D N/ L= 10/ 25mkd fetal wt dec ascribed to maternal Bwt dec., but unsure of maternal Bwt dec Rangefinding ( 5 rabbits/ group) with no control weight. Invalid study, UA M N/ L= 30/ 90mkd ataxia,

motor control, dec Bwt D N/ L= 90/ mkd* M N/ L= 30/ 60 mkd Dec Bwt, food consumption D N/ L= 60/ mkd M N/ L= 100/ 200 mkd Bwt dec D N/ L= 100/ 200mkd Misshapen,

compressed & small cerebral hemisphere & compressed cranial nerve &

displaced eye M N/ L= 5/ 20mkd,

clinical signs, death D N/ L=> 20/ mkd HDT,

NC Cl O OH O O Cl Cl OH O O CH 3 Cl OH O O Cl CH 3 O ONa Cl CH 3 O OH O Study/ Test 4 chloro phenoxyacetic acid ( 4 CPA)

019401 Data from DERs &

Peer Rev ( 2,4 dichlorophenoxy) 2

acetic acid ( 2,4 D)

030001 Data from 1 Liner & Peer Rev ( 2 methyl 4

chlorophenoxy 2 acetic acid ( MCPA)

030501 Data from 1 Liner &

Paul Chin sodium ( 3 chlorophenoxy)  2

propionate ( cloprop, sodium salt)

021201 Data from 1 Liner No info in Archives ( 2 methyl 4 chlorophenoxy) 4

butyric acid ( MCPB)

019201 Data from 1 Liner Page 6 of 9 870.3800 Reproduction . . . . . . . . . 1 ( Partly unreadable 1964 5 study) P N/ L= 12.5/ B mkd Studied at too low of dose. No effects in parents or offspring.

Since parts unreadable N/ L unverifiable UA P N/ L= 5/ 20mkd kidney Off N/ L= 7.5/ 20mkd, Bwt dec ( same ppm dose as parents)* P N/ L= 225/ mkd Off N/ L= 7.5/ 225mkd possible pup Bwt dec P N/ L= 100/ 400mkd Off N/ L=

100/ 400mkdec pup Bwt dec

870.4100a Chronic Toxicity ( rodent)

870.4100b Chronic Toxicity ( dog) .  N/ L= 1/ 5mkd, liver enzyme inc, histop liver & kidney N/ L= 6/ 30mkd, liver histop & enzyme inc,

histop kidneys

870.4200a Oncogenicity ( rat) . . . . .

870.4200b Oncogenicity ( mouse) . .  N/ L= 5/ 62.5 mkd, kidney & adrenal weight inc Inadequate doses No carcinogenicity. N/ L= 15.7/ 79.5mkd histo kidney & wt &

calcification No carcinogenicity N/ L= 75/ 300 mkd liver pigmentation Equivocal oncogenicity, UA

870.4300 Chronic/ Oncogenicity ( rat) . . . . . . . . . . . . . . . .  N/ L= 5/ 75mkd, Bwt kidney, liver, liver enz &

thyroid changes Not carcinogenicity to equivocal N/ L= 1/ 4.4mkd liver enzyme inc., kidney histop No carcinogenicity N/ L= 25/ 100mkd,

liver, kid. need historical control to confirm carcinogenicity,

refused submission Not carcinogenic.  Cl O OH O O Cl Cl OH O O CH 3 Cl OH O O Cl CH 3 O ONa Cl CH 3 O OH O Study/ Test 4 chloro phenoxyacetic acid ( 4 CPA)

019401 Data from DERs &

Peer Rev ( 2,4 dichlorophenoxy) 2

acetic acid ( 2,4 D)

030001 Data from 1 Liner & Peer Rev ( 2 methyl 4

chlorophenoxy 2 acetic acid ( MCPA)

030501 Data from 1 Liner &

Paul Chin sodium ( 3 chlorophenoxy)  2

propionate ( cloprop, sodium salt)

021201 Data from 1 Liner No info in Archives ( 2 methyl 4 chlorophenoxy) 4

butyric acid ( MCPB)

019201 Data from 1 Liner Page 7 of 9 870.5100 Mutagenicity C Gene Mutation  bacterial 870.5100 Mutagenicity C Gene Mutation  bacterial . . . . Neg Neg Neg Neg Neg Neg Neg 870.5300 Mutagenicity C Gene Mutation  mammalian . Neg Pos Neg Neg 870.5375 Mutagenicity C Structural Chromosomal Aberrations . . . . . . . . . .

Nonguideline Chromosomal aberrations ( human lymphocytes)............  One pos +/ one neg  Pos.

Nonguideline Recom/ Convers Assay ( Saccharomyces)    Neg

Nonguideline Recomb/ Convers Assay ( Mouse).................    Neg

870. 5395 Mutagenicity C Structural Chromosomal Aberrations. Neg Neg Neg Neg

870.5450 Rodent Dominant Lethal    NOAEL> 400 mg/ kg Neg

870.5915 Sister Chromatid Exchange.......................  Neg + S9/ Pos  S9 Weakly Pos.   Cl O OH O O Cl Cl OH O O CH 3 Cl OH O O Cl CH 3 O ONa Cl CH 3 O OH O Study/ Test 4 chloro phenoxyacetic acid ( 4 CPA)

019401 Data from DERs &

Peer Rev ( 2,4 dichlorophenoxy) 2

acetic acid ( 2,4 D)

030001 Data from 1 Liner & Peer Rev ( 2 methyl 4

chlorophenoxy 2 acetic acid ( MCPA)

030501 Data from 1 Liner &

Paul Chin sodium ( 3 chlorophenoxy)  2

propionate ( cloprop, sodium salt)

021201 Data from 1 Liner No info in Archives ( 2 methyl 4 chlorophenoxy) 4

butyric acid ( MCPB)

019201 Data from 1 Liner Page 8 of 9 870.5550 Mutagenicity C Other Genotoxic Effects . . . . .  Neg

870.6100a Acute Delayed Neurotox.

( hen) . . . . . . . . . . . . . . .

870.6100b 90 Day Neurotoxicity ( hen) . . . . . . . . . . . . . . .

870.6200a Acute Neurotox.

Screening Battery ( rat) . .  N/ L= 67/ 227mkd altered FOB, dec coordination SystN/ L= 227/ mkd N/ L= 200/ 400mkd impaired gait males

870.6200b 90 Day Neuro. Screening Battery ( rat) . . . . . . . . . .   N/ L= 34/ 177mkd dec motor activity, grip strength, liver histo.

870.6200 One year Neuro. Toxicity study ( rat)  N/ L= 75/ 150mkd incr relative forelimb grip strength

870.6300 Develop. Neuro . . . . . . .      Cl O OH O O Cl Cl OH O O CH 3 Cl OH O O Cl CH 3 O ONa Cl CH 3 O OH O Study/ Test 4 chloro phenoxyacetic acid ( 4 CPA)

019401 Data from DERs &

Peer Rev ( 2,4 dichlorophenoxy) 2

acetic acid ( 2,4 D)

030001 Data from 1 Liner & Peer Rev ( 2 methyl 4

chlorophenoxy 2 acetic acid ( MCPA)

030501 Data from 1 Liner &

Paul Chin sodium ( 3 chlorophenoxy)  2

propionate ( cloprop, sodium salt)

021201 Data from 1 Liner No info in Archives ( 2 methyl 4 chlorophenoxy) 4

butyric acid ( MCPB)

019201 Data from 1 Liner Page 9 of 9 870.7485 General Metabolism ( Lab#

152/ 517) . . . . . . . . . . . . . . . . . . . . .

870.7600 Dermal Penetration . . .   Excreted as parent in urine ( 86 94%), 4 11% in the feces Small amounts of metabolites ( 0.6% 1.3%).

98 99.5% recovered within 48 hr.

Excreted mostly unmetabolized  Mostly excreted as MCPA, 7 13%

hydroxylated methyl MCPA. 98% excreted within 192 hr.

Excreted mostly unmetabolized  Excreted as parent,

mostly unmetabolized in the goat UC  Lit.; Bact Splits off acetic acid from the butyric acid residue in plants and cows UA

Carcogenicity Classification....................................... No studies " D" not classifiable as a human carcinogen Not likely to be a human carcinogen, but no HIARC or CARC review yet Rats ( historical control required) Chem withdrawn Mice increased pairwise hepatocellular carcinomas at HDT Unclassified by CARC No carcinogenicity studies 1 This 3 generation reproduction study with 4 CPA is reasonably well conducted but the doses were too low ( the highest dose tested was 12.5% of the NOAEL from the 90 day subchronic study in rats.). The highest dose tested was 250 ppm and the NOAEL in a 90 day rat study was 2000 ppm. In addition, the colony showed respiratory problems with weight loss with recovery and related marked cannibalism, and pup death due to maternal death. The material tested appeared to be reasonably pure from acid equivalent measurements, but since no units were reported,

this cannot be verified. The study was conducted prior to GLPs and the test material in the diet was not measured. Therefore the study is unacceptable/ not upgradable.

N/ L = NOAEL/ LOAEL followed by effects at LOAEL unless otherwise specified; mkd = mg/ kg/ day.  = No study conducted or available; UA = Unacceptable study; UC = Unclassified study; a. i. = active ingredient. inc= increase; dec= decrease; histop= histopathology; DER= data evaluation record; neg= negative; pos= positive; Syst= systemic; HDT= highest dose tested;

mod= moderate; Bwt= body weight; unoss= unossified; oss= ossification; M= maternal; D= developmental; UA= unacceptable; P= parental; Off= offspring; FOB= Functional Observation Battery;

CARC= Cancer Assessment Review Committee.


[Federal Register: March 19, 2008 (Volume 73, Number 54)]
[Rules and Regulations]
[Page 14686-14687]
[DOCID:fr19mr08-15]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

14 CFR Part 97

[Docket No. 30597; Amdt. No. 3260]

Standard Instrument Approach Procedures, and Takeoff Minimums and
Obstacle Departure Procedures; Miscellaneous Amendments

AGENCY: Federal Aviation Administration (FAA), DOT.

ACTION: Final rule.

-----------------------------------------------------------------------

SUMMARY: This Rule establishes, amends, suspends, or revokes Standard
Instrument Approach Procedures (SIAPs) and associated Takeoff Minimums
and Obstacle Departure Procedures for operations at certain airports.
These regulatory actions are needed because of the adoption of new or
revised criteria, or because of changes occurring in the National
Airspace System, such as the commissioning of new navigational
facilities, adding new obstacles, or changing air traffic requirements.
These changes are designed to provide safe and efficient use of the
navigable airspace and to promote safe flight operations under
instrument flight rules at the affected airports.

DATES: This rule is effective March 19, 2008. The compliance date for
each SIAP, associated Takeoff Minimums, and ODP is specified in the
amendatory provisions.
    The incorporation by reference of certain publications listed in
the regulations is approved by the Director of the Federal Register as
of March 19, 2008.

ADDRESSES: Availability of matters incorporated by reference in the
amendment is as follows:
    For Examination--
    1. FAA Rules Docket, FAA Headquarters Building, 800 Independence
Avenue, SW., Washington, DC 20591;
    2. The FAA Regional Office of the region in which the affected
airport is located;
    3. The National Flight Procedures Office, 6500 South MacArthur
Blvd., Oklahoma City, OK 73169 or,
    4. The National Archives and Records Administration (NARA). For
information on the availability of this material at NARA, call 202-741-
6030, or go to: http://www.archives.gov/federal_register/code_of_
federal_regulations/ibr_locations.html.
    Availability_All SIAPs and Takeoff Minimums and ODPs are available
online free of charge. Visit nfdc.faa.gov to register. Additionally,
individual SIAP and Takeoff Minimums and ODP copies may be obtained
from:
    1. FAA Public Inquiry Center (APA-200), FAA Headquarters Building,
800 Independence Avenue, SW., Washington, DC 20591; or
    2. The FAA Regional Office of the region in which the affected
airport is located.

FOR FURTHER INFORMATION CONTACT: Harry. J. Hodges, Flight Procedure
Standards Branch (AFS-420), Flight Technologies and Programs Division,
Flight Standards Service, Federal Aviation Administration, Mike
Monroney Aeronautical Center, 6500 South MacArthur Blvd., Oklahoma
City, OK 73169 (Mail Address: P.O. Box 25082, Oklahoma City, OK 73125),
telephone:<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION: This rule amends Title 14 of the Code of
Federal Regulations, Part 97 (14 CFR part 97), by establishing,
amending, suspending, or revoking SIAPs, Takeoff Minimums and/or ODPs.
The complete regulatory description of each SIAP and its associated
Takeoff Minimums or ODP for an identified airport is listed on FAA form
documents which are incorporated by reference in this amendment under 5
U.S.C. 552(a), 1 CFR part 51, and 14 CFR part 97.20. The applicable FAA
Forms are FAA Forms 8260-3, 8260-4, 8260-5, 8260-15A, and 8260-15B when
required by an entry on 8260-15A.
    The large number of SIAPs, Takeoff Minimums and ODPs, in addition
to their complex nature and the need for a special format make
publication in the Federal Register expensive and impractical.
Furthermore, airmen do not use the regulatory text of the SIAPs,
Takeoff Minimums or ODPs, but instead refer to their depiction on
charts printed by publishers of aeronautical materials. Thus, the
advantages of incorporation by reference are realized and publication
of the complete description of each SIAP, Takeoff Minimums and ODP
listed on FAA forms is unnecessary. This amendment provides the
affected CFR sections and specifies the types of SIAPs and the
effective dates of the SIAPs, the associated Takeoff Minimums, and
ODPs. This amendment also identifies the airport and its location, the
procedure, and the amendment number.

The Rule

    This amendment to 14 CFR part 97 is effective upon publication of
each separate SIAP, Takeoff Minimums and ODP as contained in the
transmittal. Some SIAP and Takeoff Minimums and textual ODP amendments
may have been issued previously by the FAA in a Flight Data Center
(FDC) Notice to Airmen (NOTAM) as an emergency action of immediate
flight safety relating directly to published aeronautical charts. The
circumstances which created the need for some SIAP and Takeoff Minimums
and ODP amendments may require making them effective in less than 30
days. For the remaining SIAPs and Takeoff Minimums and ODPs, an
effective date at least 30 days after publication is provided.
    Further, the SIAPs and Takeoff Minimums and ODPs contained in this
amendment are based on the criteria contained in the U.S. Standard for
Terminal Instrument Procedures (TERPS). In developing these SIAPs and
Takeoff Minimums and ODPs, the TERPS criteria were applied to the
conditions existing or anticipated at the affected airports. Because of
the close and immediate relationship between these SIAPs, Takeoff
Minimums and ODPs, and safety in air commerce, I find that notice and
public procedure before adopting these SIAPs, Takeoff Minimums and ODPs
are impracticable and contrary to the public interest and, where
applicable, that good cause exists for making some SIAPs effective in
less than 30 days.

Conclusion

    The FAA has determined that this regulation only involves an
established body of technical regulations for which frequent and
routine amendments are necessary to keep them operationally current.
It, therefore--(1) is not a ``significant regulatory action'' under
Executive Order 12866; (2) is not a ``significant rule'' under DOT
Regulatory Policies and Procedures (44 FR 11034; February 26, 1979);
and (3) does not warrant preparation of a regulatory evaluation as the
anticipated impact is so minimal. For the same reason, the FAA
certifies that this amendment will not have a significant economic
impact on a substantial number of small entities under the criteria of
the Regulatory Flexibility Act.

List of Subjects in 14 CFR Part 97

    Air Traffic Control, Airports, Incorporation by reference, and
Navigation (Air).

    Issued in Washington, DC, on March 7, 2008.
James J. Ballough,
Director, Flight Standards Service.

Adoption of the Amendment

0
Accordingly, pursuant to the authority delegated to me, under Title 14,
Code of Federal Regulations, part 97 (14 CFR part 97) is amended by
establishing, amending, suspending, or revoking Standard Instrument
Approach Procedures and/or Takeoff Minimums and/or Obstacle Departure
Procedures effective at 0901 UTC on the dates specified, as follows:

PART 97--STANDARD INSTRUMENT APPROACH PROCEDURES

0
1. The authority citation for part 97 continues to read as follows:

    Authority: 49 U.S.C. 106(g), 40103, 40106, 40113, 40114, 40120,
44502, 44514, 44701, 44719, 44721-44722.

0
2. Part 97 is amended to read as follows:

Effective 10 Apr 2008

Blytheville, AR, Arkansas Intl, RNAV (GPS) RWY 18, Amdt 1.
Blytheville, AR, Arkansas Intl, RNAV (GPS) RWY 36, Amdt 1.
Blytheville, AR, Arkansas Intl, Takeoff Minimums and Obstacle DP,
Orig.
Chicago, IL, Chicago Midway Intl, Takeoff Minimums and Obstacle DP,
Amdt 10.
Wichita, KS, Wichita Mid-Continent, Takeoff Minimums and Obstacle
DP, Orig.
Coldwater, MI, Branch County Memorial, RNAV (GPS) RWY 7, Amdt 1.
Coldwater, MI, Branch County Memorial, RNAV (GPS) RWY 25, Orig.
Coldwater, MI, Branch County Memorial, VOR RWY 7, Amdt 5.
Coldwater, MI, Branch County Memorial, VOR/DME RWY 25, Orig.
Coldwater, MI, Branch County Memorial, VOR RWY 25, Orig-A,
CANCELLED.
Coldwater, MI, Branch County Memorial, Takeoff Minimums and Obstacle
DP, Amdt 4.
Jackson, MN, Jackson Muni, NDB RWY 13, Amdt 10.
Higginsville, MO, Higginsville Industrial Muni, RNAV (GPS) RWY 16,
Amdt 1.
Higginsville, MO, Higginsville Industrial Muni, RNAV (GPS) RWY 34,
Amdt 1.
Tulsa, OK, Tulsa Intl, VOR OR TACAN RWY 26, Amdt 23.
Antigo, WI, Langlade County, RNAV (GPS) RWY 16, Amdt 1.
Antigo, WI, Langlade County, RNAV (GPS) RWY 34, Amdt 1.
Antigo, WI, Langlade County, NDB RWY 16, Amdt 6.
Antigo, WI, Langlade County, Takeoff Minimums and Obstacle DP, Orig.
Milton, WV, Ona Airpark, Takeoff Minimums and Obstacle DP, Amdt 2.

Effective 05 Jun 2008

Meeker, CO, Meeker, Takeoff Minimums and Obstacle DP, Amdt 1.
Telluride, CO, Telluride Rgnl, Takeoff Minimums and Obstacle DP,
Amdt 1.
Bartow, FL, Bartow Muni, Takeoff Minimums and Obstacle DP, Orig.
Bozeman, MT, Gallatin Field, NDB RWY 12, Amdt 5, CANCELLED.
Redmond, OR, Roberts Field, NDB OR GPS RWY 22, Amdt 1A, CANCELLED.
Ephrata, WA, Ephrata Muni, Takeoff Minimums and Obstacle DP, Amdt 2.
    On February 25, 2008 (73 FR 9935), the FAA published an
Amendment in Docket No. 30593, Amdt No. 3256 to Part 97 of the
Federal Aviation Regulations under section 97.33, effective April
10, 2008, which is hereby rescinded:

Lanai City, HI, Lanai, ILS OR LOC RWY 3, Orig-A.

    On February 25, 2008 (73 FR 9935), the FAA published Amendments
in Docket No. 30593, Amdt No. 3256 to Part 97 of the Federal
Aviation Regulations under section 97.33, effective April 10, 2008,
which are hereby corrected to be effective March 13, 2008:

Bishop, CA, Eastern Sierra Rgnl, RNAV (GPS) Y RWY 12, Orig.
Bishop, CA, Eastern Sierra Rgnl, RNAV (GPS) Z RWY 12, Orig.

    On February 25, 2008 (73 FR 9935), the FAA published an
Amendment in Docket No. 30593, Amdt No. 3256 to Part 97 of the
Federal Aviation Regulations under section 97.33, effective April
10, 2008, which are hereby corrected to be effective July 31, 2008:

Woodward, OK, West Woodward, NDB RWY 17, Amdt 3, CANCELLED.

 [FR Doc. E8-5172 Filed 3-18-08; 8:45 am]

BILLING CODE 4910-13-P